The Dividend Yield as of September 2024 (TTM) for Nuvectis Pharma, Inc. (NVCT) is 0%

According to Nuvectis Pharma, Inc.’s latest financial reports and current stock price. The company's current Dividend Yield is 0%. This represents a change of 0% compared to the average of 0% of the last 4 quarters.

Nuvectis Pharma, Inc. (NVCT) Historical Dividend Yield (quarterly & annually)

How has NVCT Dividend Yield performed in the past?

The mean historical Dividend Yield of Nuvectis Pharma, Inc. over the last ten years is 0%. The current 0% Dividend Yield has changed 0% with respect to the historical average. Over the past ten years (40 quarters), NVCT's Dividend Yield was at its highest in in the March 2021 quarter at 0%. The Dividend Yield was at its lowest in in the March 2021 quarter at 0%.

Nuvectis Pharma, Inc. (NVCT) Dividend Yield by Quarter and Year

Discovering the peaks and valleys of Nuvectis Pharma, Inc. Dividend Yield, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Nuvectis Pharma, Inc. (NVCT) Average Dividend Yield

How has NVCT Dividend Yield performed in the past?

The current Dividend Yield of Nuvectis Pharma, Inc. (NVCT) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Nuvectis Pharma, Inc. (NVCT) Dividend Yield vs. Peers

How is NVCT’s Dividend Yield compared to its peers?

Nuvectis Pharma, Inc.’s Dividend Yield is less than Replimune Group, Inc. (0%), less than Lyra Therapeutics, Inc. (0%), less than Kronos Bio, Inc. (0%), less than Gossamer Bio, Inc. (0%), less than Olema Pharmaceuticals, Inc. (0%), less than Larimar Therapeutics, Inc. (0%), less than Centessa Pharmaceuticals plc (0%), less than Orchestra BioMed Holdings, Inc. (0%), less than Monte Rosa Therapeutics, Inc. (0%), less than NewAmsterdam Pharma Company N.V. (0%), less than Inventiva S.A. (0%), less than Cullinan Oncology, Inc. (0%), less than Compass Therapeutics, Inc. (0%), less than Ikena Oncology, Inc. (0%), less than Aerovate Therapeutics, Inc. (0%), less than Eliem Therapeutics, Inc. (0%), less than Decibel Therapeutics, Inc. (0%), less than Anebulo Pharmaceuticals, Inc. (0%), less than Werewolf Therapeutics, Inc. (0%), less than Edgewise Therapeutics, Inc. (0%), less than Celcuity Inc. (0%), less than C4 Therapeutics, Inc. (0%),

Build a custom stock screener for Nuvectis Pharma, Inc. (NVCT) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Nuvectis Pharma, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Nuvectis Pharma, Inc. (NVCT) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Nuvectis Pharma, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.